Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Firefly Neuroscience (AIFF) Equity Ratio (2016 - 2025)

Firefly Neuroscience has reported Equity Ratio over the past 15 years, most recently at 0.73 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.73 for Q4 2025, up 994.35% from a year ago — trailing twelve months through Dec 2025 was 0.73 (up 994.35% YoY), and the annual figure for FY2025 was 0.73, up 994.35%.
  • Equity Ratio for Q4 2025 was 0.73 at Firefly Neuroscience, down from 0.78 in the prior quarter.
  • Over the last five years, Equity Ratio for AIFF hit a ceiling of 0.81 in Q2 2025 and a floor of 0.52 in Q3 2024.
  • Median Equity Ratio over the past 5 years was 0.42 (2021), compared with a mean of 0.29.
  • Biggest five-year swings in Equity Ratio: crashed 297.48% in 2024 and later soared 17643.47% in 2025.
  • Firefly Neuroscience's Equity Ratio stood at 0.75 in 2021, then crashed by 137.36% to 0.28 in 2022, then soared by 114.8% to 0.04 in 2023, then crashed by 297.48% to 0.08 in 2024, then skyrocketed by 994.35% to 0.73 in 2025.
  • The last three reported values for Equity Ratio were 0.73 (Q4 2025), 0.78 (Q3 2025), and 0.81 (Q2 2025) per Business Quant data.